IFNAR1 and neoplasm: Therefore, the poor prognosis of HNSCC patients with high IFNAR1 expression may be attributed to the strong immunosuppressive status (i.e., low CD8+ T and CD56+ NK expression, high PDL1 expression) of the tumour microenvironment.